What medication can help you stop drinking?
FDA-approved medications can help people reduce or stop drinking by targeting the brain's reward system and reducing cravings. Telehealth services now make prescription medication for alcohol use disorder accessible from home with complete privacy and medical support. FDA-approved medications can help people reduce or stop drinking by targeting
Search "medication to stop drinking" and it is easy to come away feeling there is one pill you have been missing. There isn't a single one. There are three medicines the U.S. Food and Drug Administration has approved for alcohol use disorder, and the more useful fact is that they do genuinely different jobs. One turns down the reward a drink gives. One steadies a brain that stays rattled for months after you quit. One makes drinking make you sick. Knowing which problem each one is built for is most of what an article can honestly hand you. Matching one to your body is a clinician's call, and this page will not pretend otherwise.
Three medicines, three different jobs
The common mistake is to treat these as three versions of the same promise. A peer-reviewed overview of the approved options lays them side by side, and the plain-English version is worth carrying with you.
Naltrexone turns down the reward. Part of what makes a drink feel good comes from the brain's own feel-good chemistry — the same opioid signaling that strong painkillers act on. Naltrexone parks itself on those receptors and blocks them, so the lift a drink gives is muted and, over time, feels less worth chasing. SAMHSA describes it as blocking the effects and feelings of alcohol while reducing cravings and how much people drink, and the American Academy of Family Physicians explains the logic: because opioid receptors help mediate alcohol's pleasant effects, blocking them makes drinking less reinforcing. It is FDA-indicated for alcohol dependence and does not require you to have already quit. Its firmest caution is specific: it cannot be combined with opioid pain medicine or taken by someone dependent on opioids, because it blocks those drugs too and can trigger sudden, severe withdrawal.
Acamprosate steadies the brain after you stop. Alcohol quiets the brain's main "go" signals and leans on its "calm down" ones; do that heavily for years and the brain resets around the constant tilt. Take the alcohol away and that reset lingers, which is part of why early sobriety can feel so restless and raw. Acamprosate is studied as a way to help that over-revved "go" system settle back toward normal, per the pharmacology literature. That is also why it is approved to help people stay stopped once they have already quit, rather than to help someone cut down while still drinking. It leaves the body through the kidneys instead of the liver, which is one reason it comes up for people whose liver is already strained.
Disulfiram works like a tripwire. Your body normally breaks alcohol down in stages; disulfiram blocks one of those steps so a toxic byproduct, acetaldehyde, piles up. Drink on it and you feel genuinely ill — flushing, nausea, a pounding heart. Its FDA label is blunt about the framing: it is an aid for people who want to stay in a state of enforced sobriety, and it is explicitly not a cure. The unpleasant reaction is the entire mechanism, which means it only helps someone who is committed to not drinking at all.
So the three are not ranked versions of one drug. Naltrexone makes a drink less rewarding, acamprosate calms the aftermath of quitting, and disulfiram raises the cost of the next drink. Different tools, different jobs.
What the evidence supports, and where it stops
Naming a mechanism is not the same as proving a medicine works, so the next honest question is what the research actually backs. The Agency for Healthcare Research and Quality's review of outpatient options found that oral naltrexone and acamprosate each carry the strongest evidence for helping people avoid a return to drinking, while the evidence for disulfiram against a placebo is weaker — which is why it tends to be considered for specific situations rather than as a default. The American Academy of Family Physicians reaches a similar place and adds an important rider: medication works best paired with counseling or other support, not used alone.
What the evidence cannot do is tell you which option fits you. That depends on your goal — cutting back versus staying stopped — plus your drinking history, your liver and kidneys, whether you take opioids, your mental health, and what has and hasn't worked before. Two people with the same search history can land on different medicines for good reasons. The research lists the options; it does not read your chart.
If you are wondering which one is "right"
That is the question most people actually arrive with, and it does not have a single answer. A rough way to think about it: if your aim is to drink less rather than quit entirely, the reward-dulling approach is the one usually discussed first. If you have already stopped and the problem is a restless, off-balance stretch of early sobriety, the steadying medicine is built for exactly that window. If what you want is a hard external guardrail against any drinking at all, the tripwire approach exists for that specific resolve. None of these is the "best" one; they answer different questions. A clinician's job is to match the option to your goal instead of the other way around, which is why walking in with your goal stated plainly does more than any article can.
One number worth sitting with: in 2024, an estimated 27.9 million people ages 12 and older in the United States had a past-year alcohol use disorder — about 9.7% of that age group, according to NIAAA.
Yet only about 7.6% of them received any alcohol-use treatment that year, and the share who received one of these medications is smaller still.
That gap is not evidence the medicines fail. It mostly means the conversation never happens — people are rarely offered medication, or never reach a clinician who raises it. So if you are reading this at all, you are already ahead of where most people in your position get to.
If you do not have a clinician to bring the question to, Clero connects you with a licensed clinician by telehealth who can review your history and talk through whether a medicine like naltrexone fits — the review most people never get offered, without your having to walk into a specialty clinic first.
Before any of this, one safety line
Medication choice is a calm, unhurried conversation. Stopping heavy daily drinking is sometimes not. If cutting back or quitting has ever brought on shaking, sweating, confusion, hallucinations, or a seizure, that is not something to manage alone or wait out — call 911 or go to an emergency room, because alcohol withdrawal can turn dangerous fast. And if the drinking sits alongside thoughts of harming yourself, call or text 988 to reach the Suicide and Crisis Lifeline. The medication question can wait until you are safe; these cannot.
The honest bottom line
There is no single "stop drinking" pill, but there is a real, short menu of medicines with different mechanisms and real evidence behind the two best-studied ones. The value of knowing that is not to self-prescribe from a web page — it is to walk into a clinical conversation already knowing what you want to ask and what you are aiming for. That is a smaller, safer step than the search that brought you here, and a better one.
This article is general education, not medical advice, a dosing guide, or a prescription. Any decision about medication is one to make with a licensed clinician who knows your history; for free, confidential referrals you can reach SAMHSA's National Helpline at 1-800-662-HELP.
Want the private naltrexone update?
Join the launch list to hear first. Today, this is still educational content, not a prescription request or clinical intake.